SARS-COV-2 VACCINE SUPPLY AGREEMENT
Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 inâ¯humans. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i)...
Buyer
Business Energy and Industrial Strategy
Value
£1
Published
12 Feb 2021
Closes
21 Oct 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Goods
Contract starts
21 Oct 2020
Contract ends
31 Dec 2021
CPV classifications
33651600
Vaccines
Lots
Lot default SARS-COV-2 VACCINE SUPPLY AGREEMENT
£1
Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 inâ¯humans. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld...
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
12 Feb 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
This link refers to the original notice that is corrected and superseded by this notice.
Not provided
This link refers to the original notice that is corrected and superseded by this notice.
Contract notice
SARS-COV2 VACCINE SUPPLY AGREEMENT - [REDACTED]
Not provided
SARS-COV2 VACCINE SUPPLY AGREEMENT - [REDACTED]
Contract signed · PDF
Contains public sector information licensed under the Open Government Licence v3.0.